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Abstract:
This study was conducted to assess the role of AMPK in regulating meiosis in
mouse oocytes from the germinal vesicle stage to metaphase II. Exposure of
mouse cumulus cell-enclosed oocytes (CEO) and denuded oocytes (DO)
during spontaneous maturation in vitro to AMPK-activating agents resulted in
augmentation of the rate and frequency of polar body formation. Inhibitors of
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AMPK had an opposite, inhibitory effect. In addition, the AMPK inhibitor,
compound C (Cmpd C) increased the frequency of oocyte activation. The
stimulatory action of the AMPK-activating agent, AICAR, and the inhibitory
action of Cmpd C were diminished if exposure was delayed, indicating an
early action of AMPK on polar body formation. The frequency of spontaneous
and Cmpd C-induced activation in CEO was reduced as the period of hormonal
priming was increased, and AMPK stimulation eliminated the activation
response. Immunostaining of oocytes with antibody to active AMPK revealed
an association of active kinase with chromatin, spindle poles and midbody
during maturation. Immunolocalization of the α1 catalytic subunit of AMPK
showed an association with condensed chromatin and the meiotic spindle, but
not in the spindle poles or midbody; α2 stained only diffusely throughout the
oocyte. These data suggest that AMPK is involved in a regulatory capacity
throughout maturation and helps promote the completion of meiosis while
suppressing premature activation.

INTRODUCTION
AMP-activated protein kinase (AMPK) is an important cellular
energy sensor that is activated in response to deficits in ATP and acts
by shutting down energy consumption and turning on energygenerating pathways (Hardie, 2003; Carling, 2004). It is a trimeric
protein comprised of β and γ regulatory subunits and an α catalytic
subunit and is present in all tissues studied. Two isoforms of the
catalytic subunit exist, α1 and α2 and both are present in mouse
oocytes (Downs et al, 2002). Recent studies from our lab have
demonstrated a role for AMPK in controlling the resumption of meiotic
maturation in mouse oocytes. AMPK within the oocyte can be activated
by hormones, stress and adenosine and AMP analogs, and such
activation precedes, and is a causal force for, meiotic resumption;
moreover, suppressing AMPK activity blocks meiotic induction brought
about by these different stimuli (Chen et al, 2006; Downs and Chen,
2006; LaRosa and Downs, 2006, 2007; Chen and Downs, 2008).
While AMPK involvement in meiotic resumption is well
established, much less is known about its participation in meiosis
following germinal vesicle breakdown (GVB) in mouse oocytes. It was
therefore the goal of the present study to examine how AMPK might
contribute to mouse oocyte maturation from GVB to first polar body
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extrusion. Through the use of stimulators and inhibitors of AMPK, and
immunofluorescent localization of the kinase, evidence is presented
that active AMPK associates with condensed chromatin and the meiotic
spindle and exerts a positive influence on polar body formation, while
suppressing activation.

RESULTS
Effects of AMPK Modulators on polar body formation
Activators Cumulus cell-enclosed oocytes (CEO) were cultured 16-17
h in medium containing increasing concentrations of 5aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) or AMP,
and were assessed for polar body formation. The percentage of CEO
progressing to MII in control cultures was 50-54%. AICAR stimulated a
significant increase in PB formation at the lower two doses, but at the
highest dose was inhibitory, while AMP was stimulatory at all doses
tested (Fig. 1A). The degree of stimulation was similar (a 26-27%
increase) within the two groups at the maximally effective
concentration.
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Figure 1

Effect of AMPK activation on polar body formation. (A) CEO were cultured

16-17 h in medium containing increasing concentrations of AICAR or AMP and
assessed for polar body formation; (B) CEO were cultured for 7-16 h in control
medium or medium containing 200 μM AICAR and checked every 3 h for polar body
formation; (C) DO were cultured 9 h in medium containing increasing concentrations
of AICAR, AMP or 8-Br-Ado and assessed for polar body formation; (D) DO were
cultured 8-14 h in control medium or medium containing 100 μm AICAR and assessed
every 2 h for polar body formation; (E) DO were pulsed 3 h in medium lacking
pyruvate and glucose or in medium containing 10 mM 2-D-Glc, or they were
continuously cultured in control medium or medium lacking pyruvate and glucose.
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After a total culture time of 9 h, oocytes were assessed for polar body formation. A
different letter at the top of the bar denotes a significant difference.

The action of AICAR on the kinetics of PB formation was next
tested. CEO were cultured 7, 10, 13 or 16 h in control medium or
medium containing 200 μM AICAR. In control cultures, PB formation
was initiated between 7 and 10 h of culture, with 28% of the oocytes
reaching metaphase II (MII) at 10 h and 62.5% by 17 h (Fig. 1B). The
frequency of PB formation in AICAR-treated oocytes was already 64%
after 10 h and this number peaked 6 h later at 78%. It is clear from
these data that AICAR stimulated both the rate and frequency of PB
formation. When CEO were cultured in 2 mM AMP, a comparable
increase in PB formation was observed at 10 h (average of 62% MII in
AMP-treated oocytes compared to 27% in controls; n = 3).
To determine if these agents act directly on the oocyte, similar
experiments were conducted with denuded oocytes (DO). An AICAR
dose response experiment first determined the most effective
concentration. Since preliminary experiments showed a higher PB
percentage in DO than CEO when cultured in control medium for 16-17
h (≥ 90%), the culture period for this experiment was shortened to 9
h. As shown in Fig. 1C, the effective dose for AICAR peaked at 100 μM,
with an increase in PB formation from 39% to 90%, and the highest
dose tested (500 μM) proved to be detrimental to development (22%
at MII). When 100 μM AICAR was then tested on the kinetics of PB
formation, the frequency of PB formation in DO was increased by this
agent at all time points (Fig. 1D), demonstrating a direct, stimulatory
action on the oocyte.
To test whether other AMPK-activating agents can also promote
PB formation in DO, a dose response experiment with AMP was carried
out with DO cultured for 9 h. However, at the effective concentrations
used for CEO, AMP had no significant effect on PB formation (Fig. 1C).
Another AMPK activator, 8-Br-adenosine (8-Br-Ado), that has
previously been shown to augment PB formation in CEO (Downs and
Chen, 2006), was next tested. A response curve similar to that
obtained with AICAR was observed, with the peak concentration (200
μM) increasing the PB rate by 27% (Fig. 1C).
Exposing mouse oocytes to different stresses stimulates meiotic
resumption in an AMPK-dependent manner (Larosa and Downs, 2006,
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2007). Initial experiments in which oocytes were heat stressed at 42°C
for 30-60 min produced no beneficial effect on progression to MII.
Thus, an alternative approach was utilized that stressed the oocyte at
the level of energy metabolism. In a previous study, it was shown that
the TCA cycle inhibitor, arsenite, promoted AMPK and GVB in arrested
oocytes (LaRosa and Downs, 2007). However, it was important for the
oocyte to recover from the stress and be capable of generating energy
after the stress pulse, since maturation is an active, energy-requiring
process (Downs et al, 2007). Thus, 2-deoxy-glucose (2-D-Glc) to
achieve ATP depletion in DO. This agent depletes ATP by the action of
hexokinase, since the product, 6-phospho-2-D-Glc, cannot be used in
glycolysis to generate more ATP. Three test conditions were evaluated:
(1) 3-h pulse with glucose- and pyruvate-free medium; (2) 3-h pulse
with this same medium containing 10 mM 2-D-Glc; and (3) continuous
exposure to 2-D-Glc in the absence of glucose and pyruvate. Total
culture time for all groups was 9 h. As shown in Fig. 1E, pulsing in the
presence, but not absence, of 2-D-Glc stimulated PB formation,
whereas continuous exposure to 2-D-Glc had no effect on GVB but
eliminated meiotic progression to MII.

Inhibitors If AMPK promotes PB formation, then suppressing its
activity should have the opposite effect. Indeed, when CEO were
cultured 16-17 h with the AMPK inhibitors, compound C (Zhou et al,
2001) and araA (Henin et al, 1996), suppression of meiotic
progression was observed. Both inhibitors blocked PB formation in
dose-dependent fashion, with Cmpd C the more effective agent (Fig.
2A). The highest dose of Cmpd C reduced PB formation by 44%, while
this number was decreased 24% by araA treatment. Interestingly,
Cmpd C, but not araA, stimulated oocyte activation, such that at a
concentration of 2.5 μm, 19% of the oocytes were activated compared
to 0% of controls. These oocytes displayed a prominent polar body
and pronucleus and, upon overnight culture in control medium, most
underwent some form of cleavage, though few normal two-cell stages
were observed. Rather, most of the eggs exhibited unequal cleavage
with differing degrees of cytoplasmic blebbing.
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Figure 2

Effect of AMPK inhibition on polar body formation. CEO (A) or DO (B)

were cultured for 16-17 h in medium containing increasing concentrations of
Compound C or araA and assessed for polar body formation or activation. Inhibitor
concentrations: 1, 2.5 and 5 μM Cmpd C; 1, 1.5 and 2 mM araA.

When the effect of these agents was tested on DO, Cmpd C
demonstrated a similar potency in suppressing PB formation, while the
effect of araA was less pronounced (Fig. 2B). Less activation was
observed in Cmpd C-treated DO when compared to similarly treated
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CEO, appearing only in the 2.5 μM group (9.8% activated), while no
activation was observed in araA-treated DO.

Effect of Timing the Exposure to AICAR and Cmpd C on
PB Formation and Activation
To determine when in the culture period oocytes were sensitive
to AICAR and Cmpd C treatment, CEO were cultured for 16-17 h and
exposure to these agents was delayed for 0, 2 or 4 h. As shown in Fig.
3, delaying AICAR exposure reduced the stimulation of PB formation,
suggesting an early effect of AMPK on this developmental endpoint.
Consistent with this finding was the progressive loss of inhibition by
Cmpd C of PB formation with later administration, such that when
delayed 4 h, the percentage of MII oocytes was not significantly
different than controls (43% versus 54%). This demonstrates that the
action of Cmpd C is not due to a general toxic effect. However, the
percentage of activated oocytes was similar (12-17%) regardless of
when Cmpd C exposure took place, suggesting a later, protective
action of AMPK on activation.

Figure 3

Effect of timing of exposure to AICAR and Cmpd C on polar body

formation and activation. CEO were cultured 16-17 h and were exposed to 200 μM
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AICAR or 2.5 μM Cmpd C at 0, 2 or 4 h after the onset of culture and then assessed
for polar body formation and activation.

Effects of PMSG Priming on Polar Body Formation and
Oocyte Activation
In a previous study (Downs, 1990), oocytes from mice primed
only 1 d had a significantly higher percentage of activation during
spontaneous maturation than oocytes from mice primed 2 days. This
finding was exploited to further analyze the effects of AMPK on PB
formation and activation. CEO from unprimed mice and from mice
primed for 1 d or 2 d were cultured for 21-22 h in control medium or
medium containing either 200 μM AICAR or 2.5 μm Cmpd C and then
assessed for PB formation and activation. The culture time was
extended in these experiments, because longer culture times were
shown to augment the effect on activation (Downs, 1990). These data
are presented in Figure 4A. Control oocytes from 1-d- and 2-d-primed
mice displayed identical percentages at MII (62%), with this value
reduced in oocytes from unprimed mice (47%). In all three groups,
AICAR treatment significantly stimulated PB formation (by 21-22% in
oocytes from primed animals and 46% in oocytes from unprimed
animals). As the period of priming increased, the degree of
spontaneous activation decreased (10%, 6% and 1%, respectively, in
2-d-primed, 1-d-primed and unprimed mice) as well as the extent of
Cmpd-C-stimulated activation (47%, 38% and 19%, respectively).
Moreover, spontaneous activation was completely eliminated by AICAR
treatment in all groups. These results support the idea that activation
of AMPK promotes meiotic progression to MII while, at the same time,
suppressing spontaneous activation of the oocyte. In addition, priming
mice with eCG protects the oocytes from activation during
spontaneous maturation in culture.

Molecular Reproduction and Development, Vol. 77, No. 10 (October 2010): pg. 888-899. DOI. This article is © Wiley and
permission has been granted for this version to appear in e-Publications@Marquette. Wiley does not grant permission
for this article to be further copied/distributed or hosted elsewhere without the express permission from Wiley.

9

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Figure 4

Effect of priming on polar body formation and oocyte activation. (A) CEO

were derived from unprimed mice or mice primed for 1 or 2 d, cultured 21-22 h in
control medium or medium containing 200 μM AICAR or 2.5 μM Cmpd C, and assessed
for polar body formation and activation; (B) CEO from 1-d-primed mice were cultured
15-24 h in either the absence (−) or presence (+) of 2.5 μM Cmpd C and assessed
every 3 h for polar body formation (PB) and activation (Act).

A kinetics experiment was carried out to determine the timing of
oocyte activation as it relates to PB formation. CEO from 1-d-primed
mice were cultured for varying periods of time from 15 h to 24 h in the
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presence or absence of 2.5 μM Cmpd C and assessed for PB formation
and activation. In control oocytes, the percentage of oocytes at MII
peaked at 18 h (55%) and then declined to 35% at 24 h (Fig. 4B). A
similar pattern was observed in Cmpd C-treated oocytes, but at
reduced rates, with PB frequency peaking at 26% and decreasing 6 h
later to 9%. In control oocytes, activation was initiated between 18
and 21 h of culture, at the same time PB frequency started to
decrease. The percentage of activated oocytes at 24 h (17%) was
similar to the 20% decrease in MII oocytes at this time. Activation in
Cmpd C-treated oocytes was initiated as early as 15 h (5%) and
increased rapidly thereafter, to 48% at 24 h. These data suggest that
a significant portion of the activated oocytes derived from MII-stage
oocytes.
In a separate experiment (n = 6), CEO from 1-d-primed mice
were cultured 21-22 h in MEM/BSA ± 2 mM AMP to determine if this
agent could also prevent spontaneous oocyte activation. In the
absence of AMP, 15.2 ± 3.5% of the CEO (42 out of 273) underwent
activation, as noted by the presence of a second PB and pronucleus.
AMP significantly suppressed the activation response, as only 2.5 ±
1.2% of the CEO (8 total out of 273) had responded in this manner.

Immunostaining of Active AMPK Throughout Meiotic
Maturation
Oocytes were fixed at different stages of meiotic maturation and
then stained for active AMPK using an antibody that recognizes
phospho-threonine 172 on the catalytic subunit of the kinase. Four
different maturation conditions were utilized for these experiments:
(1) in vivo maturation following hCG injection to primed animals: (2)
spontaneous maturation of CEO; and meiotic induction in (3) dbcAMParrested DO stimulated with AICAR and (4) dbcAMP-arrested CEO
stimulated with FSH. Oocytes were examined at the following meiotic
stages: GVB, metaphase I (MI), anaphase and metaphase II (MII).

Maturation in vivo In oocytes undergoing maturation in vivo in
response to hCG stimulation, active AMPK became associated with the
condensed chromosomes immediately after GVB (Fig. 5). Active AMPK
then began to move to two regions at opposite ends of the chromatin
mass, and, at MI, staining was prominently positioned at the spindle
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poles. During chromosome segregation, however, staining at the poles
disappeared and intense staining appeared in the midbody region.
After polar body formation, intense staining was often seen throughout
the polar body, but only in oocytes that had recently completed
anaphase. As the MII spindle was established, staining in the PB
disappeared and again became prominent at the spindle poles.
Specificity for active AMPK was demonstrated in MI-stage oocytes by
the disappearance of staining at the spindle poles when primary
antibody was omitted or when primary antibody was preincubated with
blocking peptide specific for the PT172 epitope (Fig. 5).
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Figure 5

Immunolocalization of active AMPK throughout oocyte maturation.

Oocytes were isolated at varying stages of meiosis after hCG administration to 2-dprimed mice, fixed and stained with anti-PT172 antibody for active AMPK (green) and
DAPI for chromatin (blue). Controls in the bottom row were of MI-stage oocytes and
were either not exposed to primary antibody or anti-PT172 antibody was first treated
with blocking peptide. GVB, germinal vesicle breakdown; MI, metaphase I, Ana,
anaphase, MII, metaphase II.

Maturation in vitro When immuofluorescence for active AMPK was
examined throughout maturation in the different in vitro model
systems, localization in all three groups was identical to that observed
in oocytes maturing in vivo (Supplementary Fig. 1). Thus, the
temporal pattern of active AMPK distribution was consistent at the
different stages of maturation regardless of whether maturation
occurred spontaneously, was induced in vivo by hCG, or was induced
in vitro by AICAR or FSH.

Immunostaining of isoforms of the catalytic subunit of
AMPK
Since there are two different isoforms of the catalytic alpha
subunit of AMPK, we examined the distribution pattern of each isoform
using isoform-specific antibodies. A light diffuse staining of alpha 2
was manifest throughout maturation with no discrete localization
associated with chromosomes or meiotic apparatus (not shown). On
the other hand, alpha 1 showed intense colocalization with condensed
chromosomes following GVB, was associated with MI and MII spindle
MTs, and colocalized with migrating chromosomes during anaphase
(Fig. 6). This stain was eliminated when primary antibody was omitted
or when primary antibody was pretreated with blocking peptide for
alpha 1. Blocking peptide for alpha 2 had no effect on alpha 1 staining.
These results are interesting in that, similar to that for active AMPK,
alpha 1 staining was associated with chromosomes and the meiotic
spindle, but the precise localization after spindle formation did not
coincide with that of the active kinase.
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Figure 6 Immunolocalization of the α1 catalytic subunit of AMPK. Oocytes were
fixed at varying stages of meiosis following hCG injection to 2-d-primed mice and
stained for with anti-α1 antibody (green) and with DAPI for chromatin (blue). Controls
in the bottom row were of MI-stage oocytes and were either not exposed to primary
antibody or anti-α1 antibody was first treated with α1 blocking peptide or α2 blocking
peptide. GVB, germinal vesicle breakdown; MI, metaphase I; Ana, anaphase; MII,
metaphase II.
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DISCUSSION
Evidence is presented that activation of AMPK in the mouse
oocyte promotes the completion of meiotic maturation and suppresses
activation, while inhibition of this kinase has the opposite results. AMP
and AICAR each stimulated an increase in both the rate and frequency
of polar body formation in spontaneously maturing oocytes. On the
other hand, Cmpd C and araA both blocked polar body formation, and
Cmpd C promoted activation. Susceptibility of oocytes to activation
was indirectly related to the extent of eCG priming; moreover, AICAR
and AMP prevented activation, while Cmpd C augmented activation.
Immunolocalization of active AMPK revealed an initial association with
condensed chromosomes after GVB and with the meiotic apparatus
thereafter, supporting a meiotic regulatory role throughout the entire
period of oocyte maturation.
Previous work has shown that AMPK activation precedes GVB in
mouse oocytes and is a causal force behind meiotic resumption (Chen
et al, 2006). The present study was conducted to determine if, after
GVB, AMPK continues to participate in the mechanisms regulating the
progression of meiosis to MII. Several lines of evidence presented
herein indicate an important role for AMPK throughout the maturation
period. Both AICAR and AMP dose-dependently increased the extent,
and accelerated the kinetics of, PB formation in spontaneously
maturing CEO, while treatment with AMPK inhibitors produced the
opposite effect. Furthermore, stressing the oocyte by depleting ATP
with 2-deoxyglucose treatment also promoted the completion of
maturation. Such treatment increases the AMP/ATP ratio and
stimulates AMPK and is often used in somatic cells to activate the
kinase (eg, Hurley et al, 2005; Zhu et al, 2005; Park et al, 2009;
Fujimoto et al, 2010; Pradelli et al, 2010). The response to 2-DG
pulsing is therefore consistent with the effects of AICAR and AMP. It
should be noted that the frequency of MII-stage control oocytes,
consistently maintained throughout the study at ~50-62%, was lower
than that reported in an earlier study utilizing similar culture
conditions (Downs and Hudson, 2000). While the reason for this
difference is not known, it is not due simply to suboptimal culture
conditions, since CEO from unprimed mice and DO from primed mice
reached MII at very high levels (~90%) and AMPK activation increased
both the extent and kinetics of PB formation.
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Because a higher number of DO than CEO progressed to the MII
stage after 16-17 h of culture, shorter time points were utilized to
assess the effects of AMPK modulators on PB formation in DO. While
AICAR increased the incidence of PB formation in DO after 9 h of
culture by over 50%, AMP curiously had no effect. An additional
activator of AMPK, 8-Br-Ado (Downs and Chen, 2008), produced a
29% increase in PB frequency. The reason for the failure of AMP to
affect maturation in DO is not known, but it is possible that uptake by
the oocyte may be hampered by removal of the cumulus cells. A
similar discrepancy in efficacy between DO and CEO was observed with
araA. Like Cmpd C, this inhibitor effectively suppressed PB formation
in CEO; however, while Cmpd C was similarly effective in DO, araA
displayed a much reduced inhibitory potency. Nevertheless, taken
together these data strongly suggest that AMPK plays an important
maturation-promoting role throughout the period from GVB to MII. It
will be important to determine how the somatic compartment
contributes to this regulation.
Additional support for AMPK involvement in the completion of
meiotic maturation was provided by the stimulation of oocyte
activation by Cmpd C during overnight culture. This is not
unprecedented, since other protein kinase inhibitors have been shown
to promote this developmental response. For example, a wide range of
studies have shown that the general kinase inhibitor, 6dimethylaminopurine, is an effective inducer of parthenogenesis in
oocytes of many mammalian species, including mouse (Szllosi et al,
1993; Liu et al, 1997; Nakasaka et al, 2000), rat (Jiang et al, 2002;
Sano et al, 2009), cat (Yin et al, 2007), rabbit (Liu et al, 2002), pig
(Leal and Liu, 1998; Jilek et al, 2001), bovine (Winger et al, 1997; Liu
et al, 1998), sheep (Loi et al, 1998; Choi et al, 2004; Alexander et al,
2006), goat (Ongeri and Krisher, 2001), camel (Wani, 2008), rhesus
monkey (Mitalipov et al, 2001) and human (Nakagawa et al, 2001).
This is due in large measure to interruption of maturation promoting
factor (MPF) activity, which is required to maintain MII arrest and is
regulated by mitogen-activated protein kinase (Fan and Sun, 2004).
Accordingly, inhibitors of the upstream kinase, MEK, also trigger
activation (Tong et al, 2003). Data herein suggest that blocking AMPK
activity in mouse oocytes interferes with this MII meiotic control point
and leads to activation, perhaps through suppression of ERK1/2
activity, though it should be noted that Cmpd C had no effect on
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ERK1/2 phosphorylation in bovine oocytes (Tosca et al, 2007). The
fact that CEO were more susceptible to activation than DO is
consistent with studies showing that cumulus cells promote activation
in aging mouse oocytes (Miao et al, 2005)
When the administration of AICAR was delayed after the onset
of culture by 2 or 4 h, there was a progressive reduction in the
stimulation of PB formation in CEO, suggesting that the increase in PB
number requires early exposure to active AMPK. This is consistent with
the finding that a similar delay in exposure to Cmpd C significantly
reduces its inhibitory activity on PB formation. However, a more
protracted period of susceptibility exists for Cmpd C-induced
activation, since comparable levels of activation were observed
whether exposure to this inhibitor occurred 0, 2 or 4 h after the onset
of culture. It therefore appears that sustained AMPK activity during a
substantial portion of the maturation period is important to maintain a
normal course of maturation and suppress oocyte activation.
In an earlier study, oocytes from 1-d-primed mice were more
susceptible to activation during spontaneous maturation than those
from mice primed 2 d (Downs, 1990). This observation was expanded
upon to further evaluate the role of AMPK in oocyte activation by
comparing oocytes from unprimed mice with those from mice primed 1
or 2 d. While less than 1% of spontaneously maturing CEO from 2-dprimed mice became activated during 17-18 h of culture, 6 or 10%
were activated in CEO from 1-d-primed or unprimed mice,
respectively. That this phenomenon was sensitive to regulation by
AMPK was supported by the observation that treatment with AICAR or
AMP suppressed oocyte activation, while Cmpd C appreciably
augmented the activation rate, most notably in the unprimed group,
where an increase from 10% to 47% was observed.
The dynamics of oocyte activation received further scrutiny in
the kinetics experiment that utilized oocytes from 1-d-primed mice,
where extending the culture time to 24 h revealed an even greater
activation response in both the absence and presence of Cmpd C. This
stems from the fact that prolonged culture lessens the ability of
oocytes to maintain MPF activity, making them more susceptible to
spontaneous and induced activation (Fissore et al, 2002). PB formation
peaked at 18 h and declined thereafter, in concert with a
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corresponding increase in activation frequency, suggesting that a
significant portion of the activated eggs originated from MII-stage
oocytes. Indeed, the 20% decrease in MII-stage oocytes in the control
group between 18 h and 24 h coincides closely with the 17% increase
in activation. However, we cannot discount the possibility that some
activated oocytes derive from MI-stage oocytes without transit through
MII, as has been reported in LT/Sv and LTXBO mouse strains whose
oocytes display high spontaneous activation rates (Kaufman and
Howlett, 1986; Maleszewski and Yanagimachi, 1995; Eppig et al, 1996,
2000). It will be interesting to determine whether AMPK activity
influences parthenogenetic activation brought about by a number of
different chemical treatments (cf, Kaufman, 1983).
In previous double immunofluorescent staining experiments
using an anti-phospho-threonine 172 antibody that targets the
phosphorylated, active α subunit of AMPK, positive staining was shown
in the GV of mouse oocytes prior to meiotic resumption and later
colocalized with condensed chromatin following GVB (Chen et al,
2008). This was consistent with a causal role for AMPK in meiotic
resumption and suggested further involvement in subsequent stages of
meiosis. Regardless of the conditions of meiotic maturation--whether
spontaneous, in situ induction via hCG injection, or in vitro induction
by AICAR or FSH treatment--immunofluorescent staining with the antiPT172 antibody revealed a reproducible pattern of localization after
GVB which further supported the participation of AMPK throughout the
entire maturation period. Active kinase appeared initially in condensed
chromosomes, became focused at the spindle poles at MI, shifted to
the midbody/cleavage furrow region during anaphase I, and then
reappeared at the spindle poles at MII.
This pattern of localization for active AMPK throughout
maturation, notably its association with the meiotic spindle, closely
resembles that found in oocytes for a number of other kinases,
including MEK1/2 (Sun et al, 2008), phospho-protein kinase C δ (Ma et
al, 2008), aurora kinase (Yao and Sun, 2005; Shuda et al, 2009) and
polo-like kinase (Wianny et al, 1998; Pahlavan et al, 2000; Tong et al,
2002; Fan et al, 2003). These kinases have all been shown to play a
vital role in meiotic maturation, particularly in relation to spindle
dynamics. The localization pattern for active AMPK in the mouse
oocyte is also identical to that recently described in dividing human
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cancer cells, mouse NIH-3T3 fibroblasts and 3T3-L1 mouse preadipocytes (Vazquez-Martin et al, 2009). These observations suggest
an important role for AMPK in cell cycle regulation.
Indeed, results of a recent genome-wide survey of protein
kinases revealed a direct link between energy sensing by AMPK and
cell cycle progression (Bettencourt-Dias et al, 2004). This relationship
was demonstrated in a study by Jones et al (2005) in which restricting
glucose availability to mouse primary mouse embryonic fibroblasts
activated AMPK and, subsequently, a p53-dependent metabolic
checkpoint; similarly, cells expressing a constitutively active α2 AMPK
catalytic subunit had impaired proliferative ability. This finding is
consistent with a recent series of reports demonstrating cessation of
cell growth and proliferation by AMPK stimulation in a variety of cell
types (eg, Imamura et al, 2001; Igata et al, 2005; Motoshima et al,
2006; Baumann et al, 2007; Gwinn et al, 2008; Fogarty and Hardie,
2009; Ishii et al, 2009; Zang et al, 2009). Further evidence stems
from the finding that mutations in the upstream AMPK kinase, LKB1
(Kyriakis, 2003), are responsible for Peutz-Jeghers syndrome, an
autosomal dominantly inherited cancer in humans (Hemminki et al,
1998; Jenne et al, 1998). LKB1 is also involved in regulation of cell
polarity through its action on AMPK (Alessi et al, 2006; Lee et al,
2007; Mirouse et al, 2007), and in mouse oocytes is present in the
germinal vesicle and is associated with the meiotic spindle, though it is
excluded from the polar microtubules and midbody (Szczepanska and
Maleszewski, 2005).
Consistent with above observations in somatic cells are the
findings that AMPK activation suppresses GVB in pigs (Mayes et al,
2007), cows (Tosca et al, 2007; Bilodeau-Goeseels et al, 2007)) and
nemertean worms (Stricker et al, 2010). However, mouse oocytes are
unique in that AMPK activation does not suppress, but, rather,
promotes cell cycle progression such that arrested GV-stage oocytes
are stimulated to reinitiate meiotic maturation (Chen et al, 2006), and
polar body formation in maturing oocytes is increased (data herein).
The effect of glucose concentrations on cell cycle regulation in mouse
oocytes likewise differs substantially from that in somatic cells.
Whereas in somatic cells lower glucose levels block cell proliferation, in
mouse oocytes it has the opposite effect. In the presence of meiotic
inhibitors, the G2/M transition is suppressed by increased glucose
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concentration, while lower glucose levels promote maturation (Downs
and Mastropolo, 1994; Downs, 1995). This may be related to the fact
that, unlike in somatic cells, glucose is not a primary energy source for
oocytes; rather, this role is taken by downstream metabolites of
glucose, such as pyruvate, that are supplied by the somatic
compartment of the follicle. Thus, meiotic inhibitors have a poor ability
to maintain meiotic arrest in mouse oocytes when pyruvate levels are
high and glucose levels are low, whereas the opposite is true when
pyruvate is low and glucose is high. Though not yet specifically
investigated, it is likely that the meiotic response of mouse oocytes to
these differing energy substrate conditions is closely related to the
activation status of AMPK. For example, glucose-derived ATP in the
cumulus cells could transit gap junctions to reach the oocyte (Downs,
1995), lower the AMP/ATP ratio and maintain AMPK in an inactive
state.
Since both type 1 and 2 α subunits for AMPK are present in the
mouse oocyte (Downs et al, 2002), it was of interest to determine the
localization pattern for each throughout maturation. The pattern for α2
was unremarkable, exhibiting a faint diffuse staining throughout the
maturation period without any localized accumulation. On the other
hand, staining for α1 showed an intense localization pattern associated
initially with the condensed chromosomes and later with the meiotic
spindle. Staining for this subunit also increased in the germinal vesicle
prior to GVB, which was surprising based on reports that α2, but not
α1, localizes to the nucleus in somatic cells (Salt et al, 1998).
Curiously, α1 stained intensely within the spindle proper at both
metaphase stages and colocalized with migrating chromosomes at
anaphase, a pattern inconsistent with that observed for the active
kinase. However, previous studies in somatic cells have failed to
demonstrate a link between the phosphorylation state of threonine 172
of AMPK and subcellular localization of the α subunit of AMPK (Kohida
et al, 2007; Vazquez-Martin et al, 2009). These results suggest that
α1, and not α2, is the catalytic subunit most important for regulating
the maturation of mouse oocytes.
In conclusion, results indicate that AMPK plays an important
regulatory role in the completion of meiotic maturation in mouse
oocytes. They also suggest that compromising AMPK activity during
meiosis has detrimental downstream effects on developmental
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potential, since although most activated oocytes from Cmpd C-treated
CEO exhibited some form of mitotic division, cleavages were clearly
abnormal, often accompanied by extensive blebbing. It will be of
interest to determine how AMPK affects preimplantation embryonic
development to see whether AMPK reverts to a suppressive influence
on cell cycle progression, as has been previously demonstrated in
mitotic cells.

MATERIALS AND METHODS
Oocyte Isolation and Culture Conditions
Animals were raised in the research colony of the principal
investigator (SMD). All experiments were carried out with prior
approval of the Marquette University Institutional Animal Care and Use
Committee.
Immature, 19-23-day-old (C57B/6J X SJL/J) F1 mice were used
for all experiments. In most experiments, mice were primed with 5 IU
equine chorionic gonadotropin (eCG) and 2 days later were killed; the
ovaries were removed and placed in culture medium where cumulus
cell-enclosed oocytes (CEO) were released from the preovulatory
follicles when poked with sterile needles. Some experiments utilized
unprimed mice or mice primed only 1 d. Denuded oocytes (DO) were
obtained by passage of CEO through mouth-operated small bore
pipets. Oocytes were washed free of other follicular tissue and
transferred to plastic tubes containing 1 ml of the appropriate test
medium. The culture medium used was Eagle’s minimum essential
medium with Earle’s salts (GIBCO/Invitrogen; Carlsbad, CA)
supplemented with 0.23 mM pyruvate, penicillin, streptomycin sulfate
and 3 mg/ml crystallized lyophilized bovine serum albumin (ICN
ImmunoBiologicals, Lisle, IL) and buffered with 26 mM bicarbonate.

Immunofluorescent Staining
Oocytes were fixed with 4% formaldehyde at 4°C and
permeabilized with 0.1% triton in blocking buffer (0.05% saponin in
PBS, pH 7.4, plus 10% sheep serum) for 30 min. Oocytes were then
washed free of triton and continuously blocked for another 90 min at
room temperature. Oocytes were incubated with rabbit primary
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antibodies (1:100) overnight at 4°C, washed in blocking buffer at
room temperature, and incubated with FITC-conjugated sheep antirabbit antibody (1:1000) at room temperature for 1 h. For
experiments involving blocking peptide, primary antibodies were
incubated for 1 h at room temp with blocking peptide before adding
oocytes for overnight incubation. After washing, oocytes were
mounted on pre-washed slides with vectashield mounting medium
containing DAPI (Vector laboratories, Inc., Burlingame, CA), and cover
slips were sealed with nail polish.

Confocal Microscopy
Oocytes were viewed on a laser scanning confocal microscope
(Carl Zeiss Co.) with a 63X objective. During imaging all settings were
kept constant, i.e., laser power, detector gain, amplifier offset,
amplifier gain and pinhole size. Digitally recorded images were
exported by LSM Examiner (Carl Zeiss Co.).

Chemicals
Saponin, dbcAMP, 8-Br-adenosine, adenine-9-β–Darabinofuranoside (araA), sheep serum, and FITC-labeled sheep antirabbit antibody were purchased from Sigma Chemical Co. (St. Louis,
MO). Compound C and AICAR were supplied by Toronto Research
Chemicals, Inc. (North York, Ontario). Anti-PT172 antibody was from
Cell Signaling Technology (Beverly, MA), and anti-PT172, anti-α1 and
anti-α2 blocking peptides were obtained from Santa Cruz Biotech, Inc.
(Santa Cruz, CA). Highly purified ovine FSH was purchased from the
National Hormone and Peptide Program (NHPP), NIDDK, and Dr. AF
Parlow.

Statistical Analysis
Oocyte maturation experiments were repeated at least three
times with at least 30 oocytes per group per experiment. Data are
reported as mean percentage GVB±SEM. Following arcsin
transformation, maturation frequencies were analyzed stastically by
ANOVA followed by Duncan’s multiple range test. For all statistical
analyses, a P value less than 0.05 was considered significant.
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Supplementary Material
Suppl Figure 1
Supplemental Figure 1. Immunolocalization of active AMPK
throughout maturation. Oocytes were fixed at varying stages of
meiosis using three different in vitro model systems: (1) spontaneous
maturation of CEO; (2) dbcAMP-arrested CEO stimulated with FSH;
and (3) dbcAMP-arrested DO stimulated with AICAR. Oocytes were
fixed and stained with anti-PT172 antibody for active AMPK (green)
and with DAPI for chromatin (blue). GVB, germinal vesicle breakdown;
MI, metaphase I; Ana, anaphase: MII, metaphase II.
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